EGFR G719C
|
NSCLC
|
EGFR G719C
|
NSCLC
|
gefitinib Sensitive: B - Late Trials
|
gefitinib Sensitive: B - Late Trials
|
EGFR G719C
|
NSCLC
|
EGFR G719C
|
NSCLC
|
erlotinib Sensitive: C2 – Inclusion Criteria
|
erlotinib Sensitive: C2 – Inclusion Criteria
|
EGFR G719C
|
NSCLC
|
EGFR G719C
|
NSCLC
|
osimertinib Sensitive: C3 – Early Trials
|
osimertinib Sensitive: C3 – Early Trials
|